We demonstrated that ExPRESSO could resolve cellular features in human brain samples, such as Aβ plaques and Tau tangles in AD-diseased brains and the characteristic morphologies of astrocytes, neurons, microglia and blood vessels. This evidence concerns the gene MAPT and Alzheimer disease.